{
  "docId": "019dd923-622b-71dc-a6da-eab730ee09ab",
  "docSlug": "d705389771f5",
  "documentTitle": "athenahealth, Inc. (ATHN)",
  "authorId": "04_Greenlight_Capital",
  "authorName": "David Einhorn",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2014-05-05 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 50,
  "pageCount": 66,
  "prevPage": 49,
  "nextPage": 51,
  "slideType": "scenario_table",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 15,
  "notes": "The slide uses a sensitivity table to challenge Morgan Stanley's valuation assumptions, specifically highlighting a shift from $72 to $7 per share.",
  "elementsJson": [
    "headline_text",
    "valuation_table",
    "paragraph",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622b-71dc-a6da-eab730ee09ab/50",
  "deckHref": "/decks/019dd923-622b-71dc-a6da-eab730ee09ab",
  "deckJsonHref": "/decks/019dd923-622b-71dc-a6da-eab730ee09ab.json",
  "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-eab730ee09ab#slide-50",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "$7 per share seems much more realistic than $72 for a product that for the most part is years away from commercial introduction, let alone success.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f40-73bb-a609-ecbd6080fcbe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "valuation per share: $7",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-3f40-73bb-a609-f124ac24ab8c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.75,
        "x": 0.13,
        "y": 0.48
      },
      "kind": "paragraph",
      "text": "So where does that leave us? While athena may be able to create an Inpatient software offering, it will be an expensive and risky undertaking... $7 per share seems much more realistic than $72.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8abec9ff-4ae7-4eb6-9df9-c36cebc5b8f8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.75,
        "x": 0.13,
        "y": 0.86
      },
      "kind": "source-note",
      "text": "Source: Morgan Stanley & Co. estimates as provided to Greenlight in April 2014 and Greenlight calculated adjustments...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "be081ccc-4d9f-4632-8c5b-fa1230073c35",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.4,
        "x": 0.3,
        "y": 0.18
      },
      "kind": "table",
      "text": "Sensitivity table showing valuation per share based on Discount Rate (10.8%, 20%, 30%) and Peak EBIT margin (10%, 15%, 20%, 25%, 30%)",
      "attrs": null,
      "subkind": "scenario",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1151cdb2-1723-4703-ba2a-8348b94541aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.2,
        "y": 0.08
      },
      "kind": "title",
      "text": "Inpatient properly discounted",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5e9252c8-e503-47a7-8680-2f54757aebb1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Scenario Analysis",
      "slug": "scenario-analysis",
      "agent": null,
      "layer": "slide",
      "matchId": "1b0834c5-db8a-4bf1-8002-9c097baa4094",
      "evidence": "Sensitivity table showing valuation per share based on Discount Rate (10.8%, 20%, 30%) and Peak EBIT margin (10%, 15%, 20%, 25%, 30%)",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "sensitivity-analysis",
      "slug": null,
      "matchId": "2632ab25-f6a7-420d-9259-6c90184f98eb",
      "evidence": "Table showing impact of varying two key variables on a final valuation output.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 66,
      "from": 25,
      "beatId": "6da4308a-36de-4167-a2e6-e90fac6c4e36",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Victory (Alternative perspective)",
      "beatSlug": "overcoming-monster-the-victory",
      "evidence": "Slides 25-66 present an alternative perspective on athenahealth's valuation and growth prospects",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}